Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (“Isodiol or the “Company“) is pleased to announce that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s OTC voluntary symbol change from “LAGBF” to “ISOLF” to better reflect the Company’s current name. The changes will be reflected at the opening of the market on August 3, 2017.About …

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (“Isodiol or the “Company“) is pleased to announce that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s OTC voluntary symbol change from “LAGBF” to “ISOLF” to better reflect the Company’s current name.
The changes will be reflected at the opening of the market on August 3, 2017.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabinoids, microencapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
The CSE has not reviewed, approved or disapproved the content of this press release.
Click here to connect with Isodiol International Inc. (CSE: ISOL) to receive an Investor Presentation.